Adenosine A1 receptor antagonists in clinical research and development (Q37769099)

22 August 2017

1 reference

title

Adenosine A1 receptor antagonists in clinical research and development (English)

1 reference

22 August 2017

Berthold Hocher

1

0 references

language of work or name

English

0 references

publication date

30 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

78

1 reference

22 August 2017

5

1 reference

22 August 2017

438-445

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.204

22 August 2017

0 references

cites work

Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Adenosine and kidney function.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Adenosine A1 receptor antagonists and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Adenosine receptors and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2010.204

1 reference

7 January 2021

Contribution of hepatic adenosine A1 receptors to renal dysfunction associated with acute liver injury in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Adenosine A1 receptor antagonist improves intradialytic hypotension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Nesiritide: trials and tribulations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Role of adenosine antagonism in the cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

A1adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2010.204

1 reference

7 January 2021

Rational use of diuretics in acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Acute decompensated heart failure and the cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

The confounding issue of comorbid renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Pharmacokinetics and pharmacodynamics of beta blockers in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Prevention of radiocontrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Regulated Overexpression of the A 1 -Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Adenosine signaling contributes to ethanol-induced fatty liver in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.204

7 January 2021

Identifiers

DOI

10.1038/KI.2010.204

1 reference

22 August 2017

1 reference

PubMed ID

20592713